aod9604 human clinical trials weight loss results efficacy Does peptide demonstrate effective fat in humans? ⚡️The peptide AOD-9604: Targets stubborn

PubMed World Anti-Doping Agency

At your request, we can send your primary care provider information about your visit

fourth bottle covers margin

Important Safety Reminders Medical Supervision Required: AOD-9604 should only be used under qualified medical supervision Baseline and monitoring laboratory testing is recommended Individual contraindications and health status must be evaluated AOD-9604 is not FDA-approved for any indication Contraindications and Precautions: Pregnancy and breastfeeding (no safety data available) Active malignancy (discuss with oncologist) Pediatric use (not studied in children) Significant organ dysfunction (limited safety data) Report Concerns: Any unexpected symptoms or adverse effects should be reported to your healthcare provider promptly

The largest Phase 2b trial (502 participants, 24 weeks) did not show statistically significant weight loss versus placebo

5-Amino-1MQ is supplied in a lyophilized (freeze-dried) form to support stability during transportation and storage